Infectious Disease

Jeanne Marrazzo, MD, MPH, on PrEP adherence in cisgender women

February 22, 2023

5 minutes watch

Source/Disclosures

Published by:

infectious disease news logo

Disclosures:
Marrazzo reports receiving consulting/advisory fees from Merck.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . ” data-action=subscribe> Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

SEATTLE — In this video, Jeanne M. Marrazzo, MD, MPH, director of the division of infectious diseases at the University of Alabama at Birmingham School of Medicine, talks about PrEP adherence and efficacy in cisgender women.

An analysis of data from more than 6,000 women collected over nearly a decade in sub-Saharan Africa and Asia found that for most, adherence declined over time.

“We obviously need other options for women who want to initiate PrEP — they’re really urgently needed,” said Marrazzo, an Infectious Disease News Editorial Board Member.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . ” data-action=subscribe> Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

Conference on Retroviruses and Opportunistic Infections (CROI)

Related Articles